ARTICLE | Clinical News
BREVAGen regulatory update
August 13, 2012 7:00 AM UTC
Genetic Technologies received CE Mark approval for its BREVAGen genetic test to determine an individual's risk of developing non-familial breast cancer. The breast cancer stratification test combines ...